Vesugen Research for Vascular Aging
An evidence-based overview of research examining Vesugen in the context of vascular aging. This page synthesizes findings from peer-reviewed literature.
Research Summary
Vesugen is proposed to counteract age-related vascular changes by modulating endothelial gene expression. In-vitro studies in aging vascular cell cultures report activated cell renewal (increased Ki-67, reduced p53) and increased sirtuin1 expression. The peptide's effects on human vascular aging are unconfirmed; no animal or controlled human trials exist.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Vesugen has not received regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.